Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Bailing Enterprise Group Heren Tang Pharmaceutical Co., Ltd. (formerly known as Guizhou Herentang Pharmaceutical Co., Ltd.) is a Chinese pharmaceutical company specializing in the research, development, production, and commercialization of traditional Chinese medicines and ethnic Miao medicines. Founded in 2001 and operating as a subsidiary of Guizhou Bailing Group Pharmaceutical Co., Ltd., the company produces a variety of herbal formulations in capsule, tablet, and granule forms. Its key commercial products include Milinqing Capsules for urinary tract infections and prostatitis, Jingdaining Capsules for dysmenorrhea, and Kangfuling Capsules for gynecological inflammation. The company operates a modern manufacturing facility in the Xiuwen County Pharmaceutical Industrial Park in Guiyang, Guizhou Province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Bailing Enterprise Group Heren Tang Pharmaceutical.